AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1
slide-2
slide-3

Docemaps RTU Injection

Prescription Icon
Prescription Required

Marketer

AMPS Biotech Pvt Ltd

Salt Composition

Docetaxel (120mg)

Overview Docemaps RTU Injection

Docetaxel ready-to-use injection is a chemotherapy agent indicated for treating breast, non-small cell lung, prostate, and head and neck cancers. Administration is exclusively by intravenous injection from a qualified healthcare professional. Dosage and frequency are determined by your physician, varying based on your specific cancer and potentially adjusted over time. Adhere strictly to your prescribed regimen; incorrect usage or overdose can lead to severe adverse reactions. Therapeutic effects may not be immediately apparent, often taking weeks or months; discontinue use only under your doctor's direction. Common side effects include shortness of breath, constipation, swelling, infections, appetite loss, myalgia, nail abnormalities, pain, and fatigue. Your doctor might prescribe additional medications to mitigate these effects. Report any unusual bleeding or bruising, sore throat, mouth sores, or fever promptly. This drug can lower blood cell counts (both red and white), increasing infection risk. Regular blood tests to monitor blood cell levels and liver function are essential. Prior to treatment, disclose any existing heart, liver, or kidney conditions, and all medications, including antibiotics, to your physician. Significant drug interactions are possible; inform your doctor of all concurrent medications. This medication is contraindicated during pregnancy and breastfeeding. Reliable contraception is crucial for both partners throughout the treatment period to prevent conception.

Uses of Docemaps RTU Injection

Cancers of the breast, lung (non-small cell), prostate, and head and neck.

Major Benefits of Docemaps RTU Injection:

This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.

Common Side effects of Docemaps RTU Injection:

  • Breathlessness
  • Constipation
  • Edema (swelling)
  • Infection
  • Loss of appetite
  • Muscle pain
  • Nail disorder
  • Pain
  • Weakness

How to use Docemaps RTU Injection:

This medication will be administered by your healthcare provider; self-medication is strictly prohibited.

How Docemaps RTU Injection works:

Docemaps RTU Injection is a cancer treatment that disrupts microtubule function, essential for cancer cell division and proliferation. This disruption inhibits cancer cell growth, leading to their eventual demise.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Do not drink alcohol while using Docemaps RTU Injection.

PregnancyPregnancyCONSULT YOUR DOCTOR

Administering Docemaps RTU Injection to pregnant individuals is contraindicated due to confirmed harm to the fetus. Exceptions may exist in extreme circumstances where a physician deems the potential benefits outweigh the known risks. Physician consultation is mandatory.

Breast feedingBreast feedingUNSAFE

Administering Docemaps RTU Injection while breastfeeding is contraindicated. Evidence indicates potential infant toxicity from this medication.

DrivingDrivingCONSULT YOUR DOCTOR

Driving ability while using Docemaps RTU Injection is undetermined. Refrain from driving if experiencing symptoms impairing concentration or reaction time.

KidneyKidneySAFE IF PRESCRIBED

Docemaps RTU Injection poses no safety concerns for patients with renal impairment; no dosage modification is necessary.

LiverLiverCAUTION

Administering Docemaps RTU Injection requires careful consideration in individuals with hepatic impairment. Dosage modification for Docemaps RTU Injection might be necessary. Physician consultation is advised.

What if you forget to take Docemaps RTU Injection :

NA

Facts to Know About Docemaps RTU Injection

LabelValue
Type of Compound Taxane-based medications
Potential for Dependence None.
Type of Medication Cancer-fighting drugs
Mechanism of Action Microtubule-disrupting drugs: Taxane class

FAQs on Docemaps RTU Injection

Weight gain is a potential side effect of Docemaps RTU Injection. This can result from fluid retention, often manifesting as initial foot swelling that may subsequently affect the entire body. Contact your physician promptly if you experience foot swelling.
Docemaps RTU Injection should be administered for the period your oncologist recommends. Treatment length depends on your specific cancer and individual response to therapy. Infusion frequency is typically every three weeks.
Docemaps RTU Injection contains alcohol, potentially causing drowsiness, dizziness, confusion, or a feeling of intoxication. This could negatively impact your ability to operate vehicles or machinery immediately following administration. Therefore, abstain from alcohol consumption while undergoing Docemaps RTU Injection treatment to prevent adverse effects.
Docemaps ready-to-use injection is frequently administered in the treatment of breast cancer, specific lung cancers, prostate cancer, gastric cancer, and cancers of the head and neck. Its mechanism of action involves inhibiting cellular growth and proliferation.
Docemaps RTU Injection is administered intravenously as a liquid solution by healthcare professionals in a clinical setting. The typical dosage regimen involves a one-hour infusion every three weeks.
Before each administration of Docemaps RTU Injection, your physician will require blood work. This will likely include a complete blood count and liver function tests to verify adequate blood cell levels and liver health for safe Docemaps RTU Injection use. Low white blood cell counts can lead to fever or infections.
Docemaps RTU Injection can cause hair loss, a frequently reported adverse reaction. Hair regrowth typically occurs following discontinuation of Docemaps RTU Injection. Nevertheless, permanent hair loss is possible. Patients experiencing concerns about hair loss should seek medical advice.
Docemaps RTU Injection can lead to edema (swelling in the extremities) and serious allergic reactions. Prophylactic corticosteroids (dexamethasone) are administered to all patients for three days, commencing one day before Docemaps RTU Injection is given, to mitigate these risks. For individuals with metastatic castration-resistant prostate cancer, the prescribed dexamethasone regimen involves oral administration at 12, 3, and 1 hour before Docemaps RTU Injection infusion.
Docemaps RTU Injection is a taxoid, a class of anticancer drugs. Its mechanism of action involves inhibiting the proliferation and metastasis of malignant cells.
Docemaps RTU Injection
12,722
MRP 15,500
17% off